RxSight (RXST) Profit After Tax (2020 - 2026)
RxSight (RXST) posted Profit After Tax of -$16.0 million for Q1 2026, up 58.79% on a QoQ basis from -$38.8 million in Q4 2025, and down 91.87% year-over-year from -$196.9 million in Q1 2025.
RxSight (RXST) Profit After Tax (2020 - 2026) Analysis & Trends
RxSight's Profit After Tax history runs 7 years deep, the most recent figure standing at -$16.0 million for Q1 2026.
- Quarterly Profit After Tax fell 91.87% year-over-year to -$16.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$76.4 million (down 186.35% YoY) and the FY2025 annual result came in at -$38.9 million, down 41.85% from the prior year.
- Profit After Tax was -$16.0 million for Q1 2026 at RxSight, up from -$38.8 million in the prior quarter.
- Across five years, Profit After Tax topped out at -$5.9 million in Q4 2024 and bottomed at -$38.8 million in Q4 2025.
- A 5-year average of -$13.4 million and a median of -$12.4 million in 2023 frame the typical range for Profit After Tax.
- Annual changes were most pronounced in 2022 — Profit After Tax soared 67.93% — and 2025, when it plunged 554.08%.
- RxSight's Profit After Tax stood at -$15.6 million in 2022, then surged by 41.79% to -$9.1 million in 2023, then jumped by 34.65% to -$5.9 million in 2024, then plunged by 554.08% to -$38.8 million in 2025, then jumped by 58.79% to -$16.0 million in 2026.
- Business Quant data shows RXST's Profit After Tax at -$16.0 million in Q1 2026, -$38.8 million in Q4 2025, and -$9.8 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 1.08 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 745.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 1.26 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 1.34 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 380.70 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 199.50 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 170.93 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 411.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | RxSight | 221.81 Mn | -196.39 Mn | 23.50 Mn | -16.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -16.00 Mn |
| Dec 31, 2025 | -38.84 Mn |
| Sep 30, 2025 | -9.82 Mn |
| Jun 30, 2025 | -11.79 Mn |
| Mar 31, 2025 | -8.34 Mn |
| Dec 31, 2024 | -5.94 Mn |
| Sep 30, 2024 | -6.34 Mn |
| Jun 30, 2024 | -6.08 Mn |
| Mar 31, 2024 | -9.10 Mn |
| Dec 31, 2023 | -9.09 Mn |
| Sep 30, 2023 | -12.40 Mn |
| Jun 30, 2023 | -13.80 Mn |
| Mar 31, 2023 | -13.21 Mn |
| Dec 31, 2022 | -15.61 Mn |
| Sep 30, 2022 | -16.77 Mn |
| Jun 30, 2022 | -16.73 Mn |
| Mar 31, 2022 | -17.60 Mn |
| Dec 31, 2021 | -48.68 Mn |
| Sep 30, 2021 | -12.67 Mn |
| Jun 30, 2021 | -13.48 Mn |